DALLAS-DSC Communications Corp. said Stet Hellas has completed interoperability testing of DSC’s A-Infusion platform, and this month signed an agreement with Stet for the platform.
“The DSC A-Infusion product gives us the ability to design and deploy in a quick and flexible manner new cellular services,” said Nikos Tsolas, executive director of network development and operations for Stet. “It is the only way forward in order for us to fulfill customer requirements and position ourselves accordingly in a highly competitive market.”
